Promotional price valid on web orders only. Your contract pricing may differ. Interested in signing up for a dedicated account number?
Learn More

AM 281, Tocris Bioscience™

Catalog No. 111510
Click to view available options
Quantity:
10 mg
50 mg
This item is not returnable. View return policy
This item is not returnable. View return policy

Potent and selective CB1 inverse agonist

Potent, selective CB1 cannabinoid receptor antagonist/inverse agonist (Ki values are 12 and 4200 nM for CB1 and CB2 receptors respectively). Increases locomotor activity following systemic administration in vivo. Analog of SR141716A (Ki = 14 nM).

Chemical Identifiers

CAS 202463-68-1
Molecular Formula C21H19Cl2IN4O2
Molecular Weight (g/mol) 557.21
MDL Number MFCD01861180
InChI Key AJFFBPZYXRNAIC-UHFFFAOYSA-N
Synonym unii-sbp4a4dyh2, sbp4a4dyh2, 1-2,4-dichlorophenyl-5-4-iodophenyl-4-methyl-n-4-morpholinyl-1h-pyrazole-3-carboxamide, 1-2,4-dichlorophenyl-5-4-iodophenyl-4-methyl-n-morpholin-4-ylpyrazole-3-carboxamide, 1-2,4-dichlorophenyl-5-4-iodophenyl-4-methyl-n-morpholino-1h-pyrazole-3-carboxamide, 1-2,4-dichlorophenyl-5-4-iodophenyl-4-methyl-n-morpholin-4-yl pyrazole-3-carboxamide, tocris-1115, d0ud9h, gtpl741, 1h-pyrazole-3-carboxamide, 1-2,4-dichlorophenyl-5-4-iodophenyl-4-methyl-n-4-morpholinyl
PubChem CID 4302962
IUPAC Name 1-(2,4-dichlorophenyl)-5-(4-iodophenyl)-4-methyl-N-(morpholin-4-yl)-1H-pyrazole-3-carboxamide
SMILES CC1=C(N(N=C1C(=O)NN1CCOCC1)C1=C(Cl)C=C(Cl)C=C1)C1=CC=C(I)C=C1

Specifications

Quantity 10 mg
Formula Weight 557.22
Percent Purity >99%
Chemical Name or Material AM 281
Recommended Storage Desiccate at +4°C
Product Content Correction

Your input is important to us. Please complete this form to provide feedback related to the content on this product.

Product Title

By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.

Your feedback has been submitted: Thank you for helping us improve our website.